Home > Publications database > CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver. > print

001     179131
005     20240229145533.0
024 7 _ |a 10.1038/s41596-021-00677-0
|2 doi
024 7 _ |a pmid:35288718
|2 pmid
024 7 _ |a 1750-2799
|2 ISSN
024 7 _ |a 1754-2189
|2 ISSN
024 7 _ |a altmetric:124631789
|2 altmetric
037 _ _ |a DKFZ-2022-00488
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Kaltenbacher, Thorsten
|b 0
245 _ _ |a CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver.
260 _ _ |a Basingstoke
|c 2022
|b Nature Publishing Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1651581810_6243
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2022 Apr;17(4):1142-1188
520 _ _ |a Genetically engineered mouse models (GEMMs) transformed the study of organismal disease phenotypes but are limited by their lengthy generation in embryonic stem cells. Here, we describe methods for rapid and scalable genome engineering in somatic cells of the liver and pancreas through delivery of CRISPR components into living mice. We introduce the spectrum of genetic tools, delineate viral and nonviral CRISPR delivery strategies and describe a series of applications, ranging from gene editing and cancer modeling to chromosome engineering or CRISPR multiplexing and its spatio-temporal control. Beyond experimental design and execution, the protocol describes quantification of genetic and functional editing outcomes, including sequencing approaches, data analysis and interpretation. Compared to traditional knockout mice, somatic GEMMs face an increased risk for mouse-to-mouse variability because of the higher experimental demands of the procedures. The robust protocols described here will help unleash the full potential of somatic genome manipulation. Depending on the delivery method and envisaged application, the protocol takes 3-5 weeks.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Löprich, Jessica
|0 0000-0001-9337-9539
|b 1
700 1 _ |a Maresch, Roman
|b 2
700 1 _ |a Weber, Julia
|b 3
700 1 _ |a Müller, Sebastian
|b 4
700 1 _ |a Oellinger, Rupert
|b 5
700 1 _ |a Groß, Nina
|b 6
700 1 _ |a Griger, Joscha
|b 7
700 1 _ |a de Andrade Krätzig, Niklas
|b 8
700 1 _ |a Avramopoulos, Petros
|0 0000-0001-6494-9432
|b 9
700 1 _ |a Ramanujam, Deepak
|0 0000-0003-4854-6355
|b 10
700 1 _ |a Brummer, Sabine
|b 11
700 1 _ |a Widholz, Sebastian A
|b 12
700 1 _ |a Bärthel, Stefanie
|b 13
700 1 _ |a Falcomatà, Chiara
|b 14
700 1 _ |a Pfaus, Anja
|b 15
700 1 _ |a Alnatsha, Ahmed
|b 16
700 1 _ |a Mayerle, Julia
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Schmidt-Supprian, Marc
|0 P:(DE-He78)720305ad01dd457e6342703fe99816d8
|b 18
|u dkfz
700 1 _ |a Reichert, Maximilian
|b 19
700 1 _ |a Schneider, Günter
|0 0000-0003-1840-4508
|b 20
700 1 _ |a Ehmer, Ursula
|0 0000-0002-0441-1953
|b 21
700 1 _ |a Braun, Christian Jörg
|0 P:(DE-He78)19484c34bd0a338b52b4c22786721676
|b 22
|u dkfz
700 1 _ |a Saur, Dieter Karl Maximilian
|0 P:(DE-He78)ff492c619ece40dbfbc80b938bb5deb0
|b 23
|u dkfz
700 1 _ |a Engelhardt, Stefan
|b 24
700 1 _ |a Rad, Roland
|0 P:(DE-He78)340f7c2dcaedeae68e4a62c281c7350b
|b 25
|u dkfz
773 _ _ |a 10.1038/s41596-021-00677-0
|0 PERI:(DE-600)2244966-8
|n 4
|p 1142-1188
|t Nature protocols
|v 17
|y 2022
|x 1750-2799
909 C O |p VDB
|o oai:inrepo02.dkfz.de:179131
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)720305ad01dd457e6342703fe99816d8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)19484c34bd0a338b52b4c22786721676
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 23
|6 P:(DE-He78)ff492c619ece40dbfbc80b938bb5deb0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 25
|6 P:(DE-He78)340f7c2dcaedeae68e4a62c281c7350b
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-03
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-03
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-17
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT PROTOC : 2021
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-17
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NAT PROTOC : 2021
|d 2022-11-17
920 1 _ |0 I:(DE-He78)MU01-20160331
|k MU01
|l DKTK MU LMU zentral
|x 0
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)MU01-20160331
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21